| Jennifer Jianfang Feng, MD | |
|
822 Kumho Dr, Ste 202, Fairlawn, OH 44333-9297 | |
| (330) 576-0500 | |
| (330) 576-0467 |
| Full Name | Jennifer Jianfang Feng |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 38 Years |
| Location | 822 Kumho Dr, Fairlawn, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518986710 | NPI | - | NPPES |
| P00340811 | Other | OH | RAILROAD MEDICARE |
| 7113896 | Other | OH | AETNA |
| 2675056 | Medicaid | OH | |
| 000000518269 | Other | OH | ANTHEM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 35086887 (Ohio) | Secondary |
| 207R00000X | Internal Medicine | 35-086887 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Summa Health System | Akron, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| 4m Hospitalist Services, Llc | 0446480966 | 77 |
News Archive
Secretary of State Hillary Rodham Clinton kicked off a seven country, 11-day trip — "her longest overseas journey to date as the top U.S. diplomat — by flying Monday night to Kenya where she will address an African trade and development forum, meet top Kenyan officials and see the beleaguered president of lawless Somalia's interim government," the Associated Press reports.
New York University College of Nursing's (NYUCN) Joyce K. Anastasi, PhD, DrNP, FAAN, LAc., the Independence Foundation Endowed Professor and Founding Director of the Division of Special Studies in Symptom Management at NYUCN has been awarded a $2.5 million four-year National Institutes of Health (NIH) grant for the study of "Symptom management for irritable bowel syndrome (IBS) constipation".
Researchers at Princeton, Columbia and Harvard have created a new method to analyze big data that better predicts outcomes in health care, politics and other fields.
SANUWAVE Health, Inc., an emerging medical technology company focused on the development and commercialization of non-invasive, biological response activating devices in the regenerative medicine area, today announced that patient enrollment was completed in March in its dermaPACE™ Phase III pivotal, randomized, double-blinded, sham controlled, multicenter clinical trial comparing its Pulsed Acoustic Cellular Expression technology, utilizing the dermaPACE™ tissue regeneration device, to sham control for the treatment of diabetic foot ulcers.
The shells of a common plant virus, inhaled into a lung tumor or injected into ovarian, colon or breast tumors, not only triggered the immune system in mice to wipe out the tumors, but provided systemic protection against metastases, researchers from Case Western Reserve University and Dartmouth University report.
› Verified 7 days ago
| Entity Name | Inpatient Medical Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093756314 PECOS PAC ID: 6406753045 Enrollment ID: O20031212000790 |
News Archive
Secretary of State Hillary Rodham Clinton kicked off a seven country, 11-day trip — "her longest overseas journey to date as the top U.S. diplomat — by flying Monday night to Kenya where she will address an African trade and development forum, meet top Kenyan officials and see the beleaguered president of lawless Somalia's interim government," the Associated Press reports.
New York University College of Nursing's (NYUCN) Joyce K. Anastasi, PhD, DrNP, FAAN, LAc., the Independence Foundation Endowed Professor and Founding Director of the Division of Special Studies in Symptom Management at NYUCN has been awarded a $2.5 million four-year National Institutes of Health (NIH) grant for the study of "Symptom management for irritable bowel syndrome (IBS) constipation".
Researchers at Princeton, Columbia and Harvard have created a new method to analyze big data that better predicts outcomes in health care, politics and other fields.
SANUWAVE Health, Inc., an emerging medical technology company focused on the development and commercialization of non-invasive, biological response activating devices in the regenerative medicine area, today announced that patient enrollment was completed in March in its dermaPACE™ Phase III pivotal, randomized, double-blinded, sham controlled, multicenter clinical trial comparing its Pulsed Acoustic Cellular Expression technology, utilizing the dermaPACE™ tissue regeneration device, to sham control for the treatment of diabetic foot ulcers.
The shells of a common plant virus, inhaled into a lung tumor or injected into ovarian, colon or breast tumors, not only triggered the immune system in mice to wipe out the tumors, but provided systemic protection against metastases, researchers from Case Western Reserve University and Dartmouth University report.
› Verified 7 days ago
| Entity Name | Select Specialty Hospital - Akron Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649276593 PECOS PAC ID: 7113089244 Enrollment ID: O20091124000207 |
News Archive
Secretary of State Hillary Rodham Clinton kicked off a seven country, 11-day trip — "her longest overseas journey to date as the top U.S. diplomat — by flying Monday night to Kenya where she will address an African trade and development forum, meet top Kenyan officials and see the beleaguered president of lawless Somalia's interim government," the Associated Press reports.
New York University College of Nursing's (NYUCN) Joyce K. Anastasi, PhD, DrNP, FAAN, LAc., the Independence Foundation Endowed Professor and Founding Director of the Division of Special Studies in Symptom Management at NYUCN has been awarded a $2.5 million four-year National Institutes of Health (NIH) grant for the study of "Symptom management for irritable bowel syndrome (IBS) constipation".
Researchers at Princeton, Columbia and Harvard have created a new method to analyze big data that better predicts outcomes in health care, politics and other fields.
SANUWAVE Health, Inc., an emerging medical technology company focused on the development and commercialization of non-invasive, biological response activating devices in the regenerative medicine area, today announced that patient enrollment was completed in March in its dermaPACE™ Phase III pivotal, randomized, double-blinded, sham controlled, multicenter clinical trial comparing its Pulsed Acoustic Cellular Expression technology, utilizing the dermaPACE™ tissue regeneration device, to sham control for the treatment of diabetic foot ulcers.
The shells of a common plant virus, inhaled into a lung tumor or injected into ovarian, colon or breast tumors, not only triggered the immune system in mice to wipe out the tumors, but provided systemic protection against metastases, researchers from Case Western Reserve University and Dartmouth University report.
› Verified 7 days ago
| Entity Name | 4m Hospitalist Services, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508288531 PECOS PAC ID: 0446480966 Enrollment ID: O20140303000908 |
News Archive
Secretary of State Hillary Rodham Clinton kicked off a seven country, 11-day trip — "her longest overseas journey to date as the top U.S. diplomat — by flying Monday night to Kenya where she will address an African trade and development forum, meet top Kenyan officials and see the beleaguered president of lawless Somalia's interim government," the Associated Press reports.
New York University College of Nursing's (NYUCN) Joyce K. Anastasi, PhD, DrNP, FAAN, LAc., the Independence Foundation Endowed Professor and Founding Director of the Division of Special Studies in Symptom Management at NYUCN has been awarded a $2.5 million four-year National Institutes of Health (NIH) grant for the study of "Symptom management for irritable bowel syndrome (IBS) constipation".
Researchers at Princeton, Columbia and Harvard have created a new method to analyze big data that better predicts outcomes in health care, politics and other fields.
SANUWAVE Health, Inc., an emerging medical technology company focused on the development and commercialization of non-invasive, biological response activating devices in the regenerative medicine area, today announced that patient enrollment was completed in March in its dermaPACE™ Phase III pivotal, randomized, double-blinded, sham controlled, multicenter clinical trial comparing its Pulsed Acoustic Cellular Expression technology, utilizing the dermaPACE™ tissue regeneration device, to sham control for the treatment of diabetic foot ulcers.
The shells of a common plant virus, inhaled into a lung tumor or injected into ovarian, colon or breast tumors, not only triggered the immune system in mice to wipe out the tumors, but provided systemic protection against metastases, researchers from Case Western Reserve University and Dartmouth University report.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Jianfang Feng, MD 822 Kumho Dr, Ste 202, Fairlawn, OH 44333-9297 Ph: (330) 576-0500 | Jennifer Jianfang Feng, MD 822 Kumho Dr, Ste 202, Fairlawn, OH 44333-9297 Ph: (330) 576-0500 |
News Archive
Secretary of State Hillary Rodham Clinton kicked off a seven country, 11-day trip — "her longest overseas journey to date as the top U.S. diplomat — by flying Monday night to Kenya where she will address an African trade and development forum, meet top Kenyan officials and see the beleaguered president of lawless Somalia's interim government," the Associated Press reports.
New York University College of Nursing's (NYUCN) Joyce K. Anastasi, PhD, DrNP, FAAN, LAc., the Independence Foundation Endowed Professor and Founding Director of the Division of Special Studies in Symptom Management at NYUCN has been awarded a $2.5 million four-year National Institutes of Health (NIH) grant for the study of "Symptom management for irritable bowel syndrome (IBS) constipation".
Researchers at Princeton, Columbia and Harvard have created a new method to analyze big data that better predicts outcomes in health care, politics and other fields.
SANUWAVE Health, Inc., an emerging medical technology company focused on the development and commercialization of non-invasive, biological response activating devices in the regenerative medicine area, today announced that patient enrollment was completed in March in its dermaPACE™ Phase III pivotal, randomized, double-blinded, sham controlled, multicenter clinical trial comparing its Pulsed Acoustic Cellular Expression technology, utilizing the dermaPACE™ tissue regeneration device, to sham control for the treatment of diabetic foot ulcers.
The shells of a common plant virus, inhaled into a lung tumor or injected into ovarian, colon or breast tumors, not only triggered the immune system in mice to wipe out the tumors, but provided systemic protection against metastases, researchers from Case Western Reserve University and Dartmouth University report.
› Verified 7 days ago
Dr. Teri Sanor, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 822 Kumho Dr, Medical Education, Fairlawn, OH 44333 Phone: 330-576-0500 Fax: 330-576-0467 | |
Saba Sheik, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 822 Kumho Dr, Ste 202, Fairlawn, OH 44333 Phone: 330-576-0500 Fax: 330-576-0467 | |
Joong Shin, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 822 Kumho Dr, Suite 202, Fairlawn, OH 44333 Phone: 330-576-0500 Fax: 330-576-0467 | |
Steven B Parker, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 822 Kumho Dr, Ste 202, Fairlawn, OH 44333 Phone: 330-576-0500 Fax: 330-576-0467 | |
Benita Yong Wu, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 3600 W Market St Ste 200, Fairlawn, OH 44333 Phone: 330-666-2700 | |
John Fu, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 822 Kumho Dr, Suite 202, Fairlawn, OH 44333 Phone: 330-576-0500 Fax: 330-576-0467 | |
Anthony J Muni, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 822 Kumho Dr, Suite 202, Fairlawn, OH 44333 Phone: 330-576-0500 Fax: 330-576-0467 |